Z. Wu, G. Yang, X. Zhao, J. Wu, and S. Wu
Vol 000
(d, J = 3.6 Hz, 2H, pyridine H), 5.73 (s, 1H, NH), 4.28 (s,
2H, CH2). 13C-NMR (125 MHz, DMSO-d6) δ 154.0,
149.9, 139.7, 128.9, 127.7, 127.4, 108.0, 45.8.
151.2, 149.8, 147.7, 147.1, 139.8, 139.6, 129.5, 126.8,
121.9, 120.1, 119.9, 49.5, 29.9, 20.1, 13.8. IR (KBr
cmÀ1): νmax 3398, 3065, 2948, 2913, 2872, 1655, 1584,
1559, 1481, 1438, 1420, 1394, 1381, 1290, 1234, 1064,
1050, 986, 694 cmÀ1. MS (ESI): m/z 424 [M + H]+.
Anal. Calcd for C19H17ClF3N5O: C, 53.85; H, 4.04; N,
16.52; Found: C, 54.14; H, 4.36; N, 16.71.
General procedure for the preparation of intermediate 3.
2, 3-Dichloropyridine (20.0 g, 135.1 μmol) and 80%
hydrazine hydrate (67.7 g, 1.4 mmol) were added into a
250-mL three-round bottom flask. The reaction mixture
was refluxed for 3 h, cooled to room temperature, and
filtered; the residue was washed by ethanol, dried, and
obtained 3, white solid, yield 93.0%, m.p. 161–162°C. 1H-
NMR (500 MHz, DMSO-d6) δ 8.04 (d, J = 5.1 Hz, 1H,
pyridine H), 7.61 (s, 1H, NH), 7.57 (d, J = 7.6 Hz,
pyridine H), 6.61 (dd, J = 5.1 Hz, J = 7.6 Hz, 1H, pyridine
H), 4.21 (s, 2H, NH2); 13C-NMR (125 MHz, DMSO-d6) δ:
156.3, 146.2, 136.7, 114.1, 113.7.
N-Isobutyl-1-(3-chloropyridin-2-yl)-N-(pyridin-4-yl)-5-
(trifluoromethyl)-1H-pyrazole-4-carboxamide (7c).
White
1
solid, yield 57%, m.p. 202–203°C. H-NMR (500 MHz,
CDCl3) δ 8.72 (d, J = 4.7 Hz, 1H, pyridine H), 8.50
(d, J = 4.6 Hz, 2H, pyridine H), 8.16 (d, J = 8.0 Hz, 1H,
pyridine H), 7.96 (s, 1H, pyrazole H), 7.54 (dd, J = 7.0,
4.6 Hz, 1H, pyridine H), 7.26 (d, J = 4.8 Hz, 2H,
pyridine H), 3.54 (d, J = 13.9 Hz, 2H, CH2), 2.27–1.80
(m, 1H, CH), 1.25 (d, J = 14.6 Hz, 6H, 2CH3). 13C-NMR
(125 MHz, CDCl3) δ 159.3, 150.7, 148.0, 147.3, 145.0,
140.5, 139.8, 137.8, 129.3, 127.0, 123.5 120.0, 114.1,
57.6, 29.8, 21.5. IR (KBr cmÀ1): νmax 3479, 2945, 2919,
2830, 1696, 1627, 1528, 1480, 1419, 1383, 1363, 1330,
1300, 1246, 1061, 1035, 999, 880751 cmÀ1. MS (ESI):
m/z 424 [M + H]+. Anal. Calcd for C19H17ClF3N5O: C,
53.85; H, 4.04; N, 16.52; Found: C, 53.45; H, 4.46; N,
16.76.
General procedure for the preparation of the target
compounds 7a–7e.
Intermediates 2 (586.4 μmol), 6
(645.0 μmol), NaH (2.4 mmol), and anhydrous
tetrahydrofuran (5 mL) were added into a 25-mL three-
round bottom flask. The reaction mixture was stirred at
room temperature for 10 h. The organic solvent was
removed under reduced pressure. Afterward, the residue
was re-dissolved by ethyl acetate (20 mL). Finally, the
organic layer was washed by saturated salt water, dried
with anhydrous sodium sulfate, and filtered; the solvent
was then removed under vacuum. The crude residue was
further purified by flash column chromatography (PE/
N-Isopentyl-1-(3-chloropyridin-2-yl)-N-(pyridin-4-yl)-5-
(trifluoromethyl)-1H-pyrazole-4-carboxamide (7d).
White
1
solid, yield 49%, m.p. 132–133°C. H-NMR (500 MHz,
CDCl3) δ 8.55 (d, J = 8.2 Hz, 1H, pyridine H), 8.47
(d, J = 4.6 Hz, 2H, pyridine H), 7.90 (s, 1H, pyrazole H),
7.45 (dd, J = 7.8, 5.0 Hz, 1H, pyridine H), 7.39
(d, J = 8.1, 1H, pyridine H), 7.04 (d, J = 7.2 Hz, 2H,
pyridine H), 3.95 (m, 2H, CH2) 2.18–1.11 (m, 3H, CH2
and CH), 0.90 (d, J = 12.8 Hz, 6H, 2CH3). 13C-NMR
(125 MHz, CDCl3) δ 161.3, 151.2, 149.8, 147.7, 147.2,
139.8, 139.6, 130.6, 129.5, 126.8, 121.9, 120.1, 120.0,
119.6, 118.0, 48.3, 36.5, 26.1, 22.5. IR (KBr cmÀ1): νmax
3451, 3068, 2953, 2914, 2870, 1658, 1587, 1562, 1483,
1437, 1417, 1400, 1382, 1287, 1239, 1063, 1052, 988,
692, 596 cmÀ1. MS (ESI): m/z 438 [M + H]+. Anal.
Calcd for C20H19ClF3N5O: C, 54.86; H, 4.37; N, 16.00;
Found: C, 55.13; H, 4.78; N, 16.38.
EA = 2:1) on a silica gel to obtain the desired product 7a–7e.
N-Propyl-1-(3-chloropyridin-2-yl)-N-(pyridin-4-yl)-5-
(trifluoromethyl)-1H-pyrazole-carboxamide (7a).
White
1
solid, yield 43%, m.p. 122–123°C. H-NMR (500 MHz,
CDCl3) δ 8.52 (d, J = 9.2 Hz, 1H, pyridine H), 7.90
(d, J = 7.8 Hz, 2H, pyridine H), 7.45 (dd, J = 7.0,
4.6 Hz, 1H, pyridine H), 7.39 (s, 1H, pyrazole H), 7.06
(d, J = 2.8 Hz, 2H, pyridine H), 3.90 (t, J = 7.2 Hz, 2H,
CH2), 1.64 (m, 2H, CH2), 0.94 (t, J = 7.2 Hz, 3H, CH3).
13C-NMR (125 MHz, CDCl3) δ 161.4, 151.3, 149.8,
148.0, 147.12, 139.8, 139.6, 131.5, 129.5, 126.8, 121.9,
120.1, 119.9, 118.0, 51.2, 21.2, 11.2. IR (KBr cmÀ1):
νmax 3446, 3052, 29483, 2917, 2871, 1659, 1585, 1559,
1469, 1440, 1417, 1381, 1286, 1234, 1058, 1051,
968 cmÀ1. MS (ESI): m/z 410 [M + H]+. Anal. Calcd for
N-Benzyl-1-(3-chloropyridin-2-yl)-N-(pyridin-4-yl)-5-
(trifluoromethyl)-1H-pyrazole-4-carboxamide (7e).
White
C18H15ClF3N5O: C, 52.76; H, 3.69; N, 17.09; Found: C,
52.25; H, 4.03; N, 16.93.
N-Butyl-1-(3-chloropyridin-2-yl)-N-(pyridin-4-yl)-5-
1
solid, yield 58%, m.p. 139–140°C. H-NMR (500 MHz,
CDCl3) δ 8.57 (dd, J = 4.7, 1.3 Hz, 2H, pyridine H),
8.46–8.42 (m, 1H, pyridine H), 8.28 (dd, J = 8.2, 1.2 Hz,
1H, pyridine H), 7.90 (s, 1H, pyrazole H), 7.72
(dd, J = 8.2, 4.7 Hz, 1H pyridine H), 7.33–7.18 (m, 5H,
benzene H), 7.14 (d, J = 6.0 Hz, 2H, pyridine H), 5.15
(s, 2H, CH2). 13C-NMR (125 MHz, CDCl3) δ 161.7,
151.247, 149.1, 148.3, 147.0, 140.9, 140.9, 136.8, 129.1,
129.0, 128.7, 128.3, 128.1, 122.7, 120.4, 51.9. IR (KBr
cmÀ1): νmax 3248, 3180, 3122, 3065, 3033, 2968, 1705,
1602, 1576, 1548, 1482, 1456, 1385, 1033, 980,
(trifluoromethyl)-1H-pyrazole-4-carboxamide (7b).
White
1
solid, yield 49%, m.p. 147–148°C. H-NMR (500 MHz,
CDCl3) δ 8.55 (d, J = 4.7 Hz, 1H, pyridine H), 8.47
(d, J = 4.6 Hz, 2H, pyridine H), 7.90 (d, J = 8.0 Hz, 1H,
pyridine H), 7.44 (dd, J = 8.0 Hz, 4.7 Hz, 1H, pyridine
H), 7.31 (s, 1H, pyrazole H), 7.05 (d, J = 4.8 Hz, 2H,
pyridine H), 3.92 (dd, J = 15.1, 8.3 Hz, 2H, CH2), 2.07–
1.06 (m, 4H, CH2CH2), 0.90 (dd, J = 5.9, 7.5 Hz, 3H,
CH3). 13C-NMR (125 MHz, CDCl3) δ 161.4, 151.5,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet